نتایج جستجو برای: stage renal disease esrd

تعداد نتایج: 1925918  

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004
William G Goodman

Hyperphosphataemia occurs in nearly all patients with end-stage renal disease (ESRD). In the past, the need to manage hyperphosphataemia focused primarily on its role as a contributor to secondary hyperparathyroidism and renal osteodystrophy. There is now widespread recognition that disturbances in phosphorus metabolism and/or the therapeutic measures used to manage it are important risk factor...

Journal: :The American surgeon 2009
Christopher R Schneider William Cobb Shivani Patel David Cull Cass Anna Richard Roettger

Little research has been performed in regards to the morbidity and outcomes associated with elective general surgery performed on patients with end stage renal disease (ESRD). With minimal data about the severity of disease in these patients, we sought to quantify the differences in the ESRD patient undergoing elective surgical procedures compared with matched controls. A review of all ESRD pat...

Journal: :Clinical medicine 2003
John Feehally

There are significant ethnic variations in the incidence of end-stage renal disease (ESRD). In the UK, the incidence of ESRD in South Asians and African Caribbeans is three times higher than in White Caucasians. This is partly explained by a high prevalence of diabetic nephropathy, but also by susceptibility to a wide range of other renal diseases. The relative contributions of genetic and envi...

Journal: :Blood purification 2011
Jessica Tangren Molly Nadel Michelle A Hladunewich

Pregnancy is uncommon in women with end-stage renal disease (ESRD). Fertility rates are low in women on dialysis, and physicians still frequently counsel women with ESRD against pregnancy. Advancements in the delivery of dialysis and obstetric care have led to improved live birth rates in women on dialysis, so pregnancy for young women with ESRD is now more feasible and safer. However, these pr...

2003
William M. McClellan Diane L. Frankenfield Pamela R. Frederick Steven D. Helgerson Jay B. Wish Jonathan R. Sugarman

Medicare's health care quality improvement program (HCQIP) is a national effort to improve beneficiaries' quality of care. The end stage renal disease (ESRD) HCQIP was implemented in 1994 in response to criticism about the poor quality of care received by ESRD patients. Quality improvement efforts initiated by the ESRD Networks and dialysis providers in response to the HCQIP have demonstrated s...

Journal: :International Journal of Human Genetics 2022

In China, primary glomerulonephritis is the leading cause of end-stage renal disease (ESRD), and patients who require kidney transplantation often with ESRD. Glomerulonephritis primary’s most prevalent subtype Mesangial proliferative (MsPGN). Although cell apoptosis human mesangial cells (HMCs) may be harmful in MsPGN, it plays a major role elimination excessive HMCs reparative glomerular remod...

2009
Rajani Hada

Background: End stage renal disease patients are treated with dialysis in Nepal. But there is no renal registry to indicate the burden of disease in the country. Objectives:The objective of this study is to fi nd out the incidence of ESRD on renal replacement therapy and their out come. Materials and methods: It is a retrospective analysis (audit) of all ESRD patients who had received dialysis ...

Journal: :Journal of the American Society of Nephrology : JASN 2003
Riccardo Magistroni Ning He Kairong Wang Robin Andrew Ann Johnson Patricia Gabow Elizabeth Dicks Patrick Parfrey Roser Torra Jose L San-Millan Eliecer Coto Marjan Van Dijk Martijn Breuning Dorien Peters Nadja Bogdanova Giulia Ligabue Alberto Albertazzi Nick Hateboer Kyproula Demetriou Alkis Pierides Constantinos Deltas Peter St George-Hyslop David Ravine York Pei

Autosomal dominant polycystic kidney disease (ADPKD) is a common Mendelian disorder that affects approximately 1 in 1000 live births. Mutations of two genes, PKD1 and PKD2, account for the disease in approximately 80 to 85% and 10 to 15% of the cases, respectively. Significant interfamilial and intrafamilial renal disease variability in ADPKD has been well documented. Locus heterogeneity is a m...

2015
Claire Rimes-Stigare Paolo Frumento Matteo Bottai Johan Mårtensson Claes-Roland Martling Max Bell

INTRODUCTION Prevalence of chronic kidney disease (CKD) amongst intensive care unit (ICU) admissions is rising. How mortality and risk of end-stage renal disease (ESRD) differs between those with and without CKD and with acute kidney injury (AKI) is unclear. Determining factors that increase the risk of ESRD is essential to optimise treatment, identify patients requiring nephrological surveilla...

2003

End-stage renal disease (ESRD) develops in about 1500 people each year in Australia, of whom about 1000 are over 50 years of age (a risk of about 200 per million per year). Diabetes, hypertension, impaired renal function and proteinuria are likely independent risk factors for the development of ESRD. About 5% of the general population have proteinuria and these individuals are approximately 15 ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید